Conference abstract · 2018
Conference abstractPublished 16 Feb 2019
Parkinson’s disease and Dementia: Induction and protection
Al Azhar University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease and no longer considered merely as a motor disorder where dementia may precede motor deficits and enhance their onset. Age is the most significant risk factor for the development of PD and dementia where oxidative stress increases during aging making the brain more susceptible to neurodegeneration. The exact underlying mechanism responsible for neurodegeneration progression still remains elusive and incompletely understood. Several epidemiological studies suggested that exposure to different environmental toxic agents and heavy metals increase the risk of induction and progression of neurodegenerative diseases. On the other hand, moderate cigarette smoking and coffee drinking are inversely associated with the risk of their development. Animal models of Parkinson's disease and Dementia: Typically, animal models of PD include environmental neurotoxins or genetic models (PD-related mutations model). Metal ions play a crucial role in the development of PD and dementia; excessive manganese exposure has been associated with manganism while aluminum has been linked with Alzheimer's disease and dementia. Manganism is characterized by extrapyramidal symptoms resembling idiopathic PD as well as psychiatric and cognitive deficits. Rotenone, a naturally occurring insecticide, and pesticide have been also linked to the two pathological hallmarks occur in clinical PD (motor and non-motor symptoms), but high mortality rate represents the major limitation for this model. On the other hand, the use of genetic animal models and identification of disease-relevant genes can encourage search to discover new promising disease-modifying therapies. Neuroprotection strategies of Parkinson’s disease and Dementia: Dopamine deficiency plays the central role in the pathogenesis of PD, thus it represents the focus of treatment efforts. Other neurotransmitters also play a major role in controlling symptoms that related to cognitive behaviors, depression, anxiety, and dementia. Oxidative stress, inflammation, and apoptosis are considered the main mechanisms implicated in the degeneration of dopaminergic neurons. Protein malnutrition can predict the progression of neurodegeneration by increasing oxidative damage. In general, protection and early diagnosis still represent the cornerstone and the golden strategy in delaying or preventing the progression of age-dependent neurodegeneration. The most promising PD-modifying therapies include natural products and nutrients having powerful antioxidants, antiinflammatory and antiapoptotic as well as those which promote neurotransmitters synthesis or enhance their concentration. Moreover, therapies which reduce stress, depression and promote better memory have also a significant role in delaying disease progression and in enhancing the efficacy of different treatments. On the other hand, non-drug therapies as physical training and mental activity can improve motor functions and manage non-motor symptoms.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 23 Mar 2017
Histomorphometric and Immunohistochemical Study of Lycopene Effect on Dopamine Receptors and GABA Neurons after Induction of Parkinson’s Disease in Adult Male Rats
Conference abstract · 25 Aug 2015
Neuroprotective effect of modified Chungsimyeolda-Tang, a traditional Korean herbal formula, via autophagy induction in models of Parkinson’s disease
Perspective · 27 Jul 2022
Lack of Cognitive Functioning Caused by Dementia Related to Parkinson's, Alzheimer's, and Vascular Dementia Diseases
Conference abstract · 25 Jun 2020
Euro Dementia 2019: Parkinson's disease dementia and dementia with Lewy bodies: the same disease or two entities?
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Azza A Ali”
